Your browser doesn't support javascript.
loading
Left ventricular assist device implantation via lateral thoracotomy: A systematic review and meta-analysis.
Ribeiro, Roberto V P; Lee, Jessica; Elbatarny, Malak; Friedrich, Jan O; Singh, Steve; Yau, Terrence; Yanagawa, Bobby.
Afiliación
  • Ribeiro RVP; Division of Cardiovascular Surgery, St. Michael's Hospital, Toronto, ON, Canada.
  • Lee J; Division of Cardiovascular Surgery, St. Michael's Hospital, Toronto, ON, Canada.
  • Elbatarny M; Division of Cardiovascular Surgery, St. Michael's Hospital, Toronto, ON, Canada.
  • Friedrich JO; Critical Care and Medicine Departments and Li Ka Shing Knowledge Institute, St. Michael's Hospital, and Department of Medicine and Interdepartmental Division of Critical Care, University of Toronto, Toronto, ON, Canada.
  • Singh S; Division of Cardiac Surgery, Trillium Health Partners, Toronto, ON, Canada.
  • Yau T; Division of Cardiac Surgery, Toronto General Hospital, Toronto, ON, Canada.
  • Yanagawa B; Division of Cardiovascular Surgery, St. Michael's Hospital, Toronto, ON, Canada. Electronic address: bobby.yanagawa@unityhealth.to.
J Heart Lung Transplant ; 41(10): 1440-1458, 2022 10.
Article en En | MEDLINE | ID: mdl-35953353
ABSTRACT

BACKGROUND:

Left ventricular assist device (LVAD) implantation via lateral thoracotomy can offer similar effectiveness to conventional approaches with less perioperative adverse events. We performed a systematic review and meta-analysis to determine the potential benefits of lateral thoracotomy (LT) for LVAD implantation compared to median sternotomy.

METHODS:

We searched MEDLINE and Embase databases for studies comparing continuous-flow LVAD implantation using LT with conventional sternotomy. Main outcomes were perioperative mortality and complications.

RESULTS:

Twenty-five observational studies enrolling 3072 patients were included with a median follow-up of 10 months. Perioperative mortality (30 day or in-hospital) was 7% (LT) and 14% (sternotomy); however, mortality differences were no longer statistically significant in matched/adjusted studies (RR0.86; 95%CI0.52-1.44; p = 0.58). LT was associated with decreased need for blood product transfusions (mean difference[MD] -4.7; 95%CI -7.2 to -2.3 units; p < 0.001), reoperation for bleeding (RR0.34; 95%CI0.22-0.54; p < 0.001), postoperative RVAD implantation (RR0.53; 95%CI0.36-0.77; p < 0.001), days requiring inotropes (MD -1.1; 95%CI -2.1 to -0.03 inotrope days; p = 0.04), ICU (MD -3.3; 95%CI -6.0 to -0.7 ICU days; p = 0.01), and hospital length of stay (MD -5.1; 95%CI -10.1 to -0.1 hospital days; p = 0.04) in matched/adjusted studies. Overall mortality during follow-up was significantly lower for LT in unmatched/unadjusted studies but not statistically significantly lower in matched/adjusted studies (Hazard Ratio0.82; 95%CI0.59-1.14; p = 0.24).

CONCLUSION:

LVAD implantation via LT was associated with significantly decreased need for blood products, reoperation for bleeding, and postoperative RVAD implantation. Furthermore, days on inotropic support were also lower, likely contributing to the shorter length of stay. These findings support greater use of a LT approach for carefully selected patients.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Corazón Auxiliar / Insuficiencia Cardíaca Tipo de estudio: Observational_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: J Heart Lung Transplant Asunto de la revista: CARDIOLOGIA / TRANSPLANTE Año: 2022 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Corazón Auxiliar / Insuficiencia Cardíaca Tipo de estudio: Observational_studies / Risk_factors_studies / Systematic_reviews Límite: Humans Idioma: En Revista: J Heart Lung Transplant Asunto de la revista: CARDIOLOGIA / TRANSPLANTE Año: 2022 Tipo del documento: Article País de afiliación: Canadá